These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 8508135

  • 1. Effects of estrogen-progestin replacement therapy on plasma beta-endorphin levels in menopausal women.
    Ortega E, Cuadros JL, Gonzalez AR, Ruiz E.
    Biochem Mol Biol Int; 1993 Apr; 29(5):831-6. PubMed ID: 8508135
    [Abstract] [Full Text] [Related]

  • 2. Serum estradiol and gonadotropins level in postmenopausal women with or without hormone replacement.
    Limpaphayom K, Taechakraichana N, Kittinunvorakoon C.
    J Med Assoc Thai; 1997 Mar; 80(3):147-52. PubMed ID: 9175381
    [Abstract] [Full Text] [Related]

  • 3. [Relation of serum growth hormone and estradiol levels and osteoporosis in postmenopausal women].
    Li G, Zeng M.
    Zhonghua Yi Xue Za Zhi; 1990 Jan; 70(1):16-9, 2. PubMed ID: 2157532
    [Abstract] [Full Text] [Related]

  • 4. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N, Genazzani AD, Bernardi F, Casarosa E, Pieri M, Palumbo M, Picciarelli G, Gabbanini M, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [Abstract] [Full Text] [Related]

  • 5. Adequate reduction degree of pituitary gonadotropin levels in the clinical management of short-term hormone replacement therapy of women with menopausal symptoms.
    Ushiroyama T, Sakuma K, Ikeda A, Ueki M.
    J Med; 2004 Mar; 35(1-6):281-94. PubMed ID: 18084886
    [Abstract] [Full Text] [Related]

  • 6. Estrogen replacement therapy in postmenopausal women: a study of the efficacy of estriol and changes in plasma gonadotropin levels.
    Ushiroyama T, Sakai M, Higashiyama T, Ikeda A, Ueki M.
    Gynecol Endocrinol; 2001 Feb; 15(1):74-80. PubMed ID: 11293929
    [Abstract] [Full Text] [Related]

  • 7. The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women.
    Blum I, Vered Y, Lifshitz A, Harel D, Blum M, Nordenberg Y, Harsat A, Sulkes J, Gabbay U, Graff E.
    Isr J Med Sci; 1996 Dec; 32(12):1158-62. PubMed ID: 9007144
    [Abstract] [Full Text] [Related]

  • 8. Effects of estrogen replacement therapy on estrogen receptor expression and immunoregulatory cytokine secretion in surgically induced menopausal women.
    Xia X, Zhang S, Yu Y, Zhao N, Liu R, Liu K, Chen X.
    J Reprod Immunol; 2009 Jul; 81(1):89-96. PubMed ID: 19497624
    [Abstract] [Full Text] [Related]

  • 9. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 10. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM, Fini M.
    Int J Fertil Womens Med; 2001 Dec; 46(5):248-56. PubMed ID: 11720197
    [Abstract] [Full Text] [Related]

  • 11. Estradiol, FSH and LH profiles in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
    Ausmanas MK, Tan DA, Jaisamrarn U, Tian XW, Holinka CF.
    Climacteric; 2007 Oct; 10(5):427-37. PubMed ID: 17852146
    [Abstract] [Full Text] [Related]

  • 12. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women].
    Lai A, Zhang J, Ding L.
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165
    [Abstract] [Full Text] [Related]

  • 13. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
    Pujol P, Daures JP, Thezenas S, Guilleux F, Rouanet P, Grenier J.
    Cancer; 1998 Aug 15; 83(4):698-705. PubMed ID: 9708933
    [Abstract] [Full Text] [Related]

  • 14. [Study on serum inhibin concentrations in women during menopausal transition].
    Zhang YW, Chen WL, Yu Q, Song YH, Zhou J, Zhang DY.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb 15; 38(2):98-101. PubMed ID: 12783698
    [Abstract] [Full Text] [Related]

  • 15. Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.
    Pae CU, Mandelli L, Han C, Ham BJ, Masand PS, Patkar AA, Steffens DC, De Ronchi D, Serretti A.
    Neuro Endocrinol Lett; 2008 Aug 15; 29(4):500-6. PubMed ID: 18766158
    [Abstract] [Full Text] [Related]

  • 16. Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women.
    Bernardi F, Pieri M, Stomati M, Luisi S, Palumbo M, Pluchino N, Ceccarelli C, Genazzani AR.
    Gynecol Endocrinol; 2003 Feb 15; 17(1):65-77. PubMed ID: 12724021
    [Abstract] [Full Text] [Related]

  • 17. Serum follicle-stimulating hormone and luteinizing hormone levels in women aged 35-60 in the U.S. population: the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994).
    Backer LC, Rubin CS, Marcus M, Kieszak SM, Schober SE.
    Menopause; 1999 Feb 15; 6(1):29-35. PubMed ID: 10100177
    [Abstract] [Full Text] [Related]

  • 18. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 15; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 19. Factors affecting reproductive hormones in HIV-infected, substance-using middle-aged women.
    Santoro N, Lo Y, Moskaleva G, Arnsten JH, Floris-Moore M, Howard AA, Adel G, Zeitlian G, Schoenbaum EE.
    Menopause; 2007 Jan 15; 14(5):859-65. PubMed ID: 17415019
    [Abstract] [Full Text] [Related]

  • 20. Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels.
    Bernardi F, Pluchino N, Pieri M, Begliuomini S, Lenzi E, Puccetti S, Casarosa E, Luisi M, Genazzani AR.
    Neuroendocrinology; 2006 Jan 15; 83(5-6):348-59. PubMed ID: 16931878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.